Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
Ann Oncol
; 27(12): 2257-2262, 2016 12.
Article
in En
| MEDLINE
| ID: mdl-27733374
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Cisplatin
/
Head and Neck Neoplasms
/
Antibodies, Monoclonal
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article
Country of publication:
Reino Unido